Dr. Riordan shows a video documenting the progress of a T-12 spinal cord injury patient after her combined bone marrow and umbilical cord stem cell treatment in Panama. He shows another video of a 65 year-old man (T-9) who was treated 13 years after his injury. This case illustrates the potential of treating older people whose injuries occurred many years prior to treatment.
November 30, 2012 by
Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 3 of 5)
Mesenchymal stem cell homing to tissue damage, umbilical cord stem cells historically used for anti-aging, mesenchymal stem cells role in immune system modulation, inflammation reduction and stimulating tissue regeneration, donor stem cell safety and testing, the role of HLA matching in donated umbilical cord-derived stem cells, umbilical cord blood safety data and historical use in blood transfusions, allogeneic stem cell persistence in human mothers.
November 30, 2012 by
Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 2 of 5)
Case studies of spinal cord injury patients treated with CD34+ and mesenchymal stem cells harvested from human umbilical cord Wharton’s jelly and cord blood, animal studies using mesenchymal stem cells, immunosuppression requirements in allogeneic stem cell treatments, intrathecal and intravenous administration of autologous bone marrow stem cells in spinal cord injury patients, and the role adult stem cell trophic factors in tissue regeneration.
November 30, 2012 by
Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 1 of 5)
Part 1: Dr. Riordan discusses mesenchymal stem cell sources from umbilical cord Wharton’s jelly, stem cell expansion, therapeutic potential of umbilical cord mesenchymal stem cells vs. bone marrow mesenchymal stem cells, CD34+ hematopoietic stem cells from umbilical cord blood and the scientific rationale supporting stem cell treatment of spinal cord injury.
November 30, 2012 by
Adult stem cell therapy for rheumatoid arthritis and osteoarthritis: Neil Riordan, PhD
Dr. Riordan discusses focuses on mesenchymal stem cells harvested from fat tissue and the role they play in reducing inflammation, repairing tissue and modulating the immune system.
November 30, 2012 by
Stem cell therapy for multiple sclerosis and rheumatoid arthritis: scientific rationale
Neil Riordan PhD presents the scientific rationale for using adipose tissue-derived stem cells and T-regulatory cells to treat MS and rheumatoid arthritis. Dr. Riordan is the Founder and President of the Stem Cell Institute in Panama City, Panama.
November 30, 2012 by
Adult stem cell therapy: side-effects of umbilical cord derived stem cells
Dr. Neil Riordan presents data on human umbilical cord-derived stem cell treatments. Dr. Riordan is Founder of the Stem Cell Institute in Panama City, Panama.
November 30, 2012 by
Jorge Paz MD: Adult stem cell therapy for arthritis, sports injury, and autoimmune diseases (part 2 of 3)
Stem cell Treatment protocol for autoimmune diseases such as rheumatoid arthritis. Why stem cells must be administered systemically for autoimmune diseases. Dr. Paz elaborates on the disadvantages of same-day fat-derived stem cell treatments. He presents the scientific rationale for treating rheumatoid arthritis (RA) with fat-derived stem cells along with a published case report including patient video. Presentation of similarities between MS and RA and how MS is treated with a combination of human umbilical cord-derived stem cells and adipose stem cells. Dr. Paz discusses why MS treatment includes umbilical cord-derived stem cells.
November 30, 2012 by
Jorge Paz MD: Adult stem cell therapy for arthritis, sports injury, and autoimmune diseases (part 1 of 3)
In Part 1 of 3 Dr. Paz discusses his internal medicine background in New York and Texas, and how he got involved with stem cell treatments in Panama. He highlights why licensing, technology and quality control make the Stem Cell Institute in Panama different from other clinics around the world. Dr. Paz then touches on why “same-day” fat-derived stem cell treatments are less than ideal. He concludes part 1 by discussing several US universities with which the Stem Cell Institute has collaborated on research.
Dr. Paz is the Medical Director at The Stem Cell Institute in Panama City, Panama
November 30, 2012 by
Clinical advances in adult stem cell therapy: Dr. Jorge Paz Rodriguez (Miami)
Current treatments with Adipose-, Bone Marrow- and Cord Blood-derived stem cells. Autism, Spinal Cord Injury, Heart Failure, Rheumatoid Arthritis and Osteoarthritis treatments are outlined. Dr. Paz is the Medical Director of the Stem Cell Institute in Panama City, Panama. He is U.S. Medical Board certified in Internal Medicine.
